- Page 3/4
- Next Page
Good solid gas, and an increasing oil producer now. On all commodity companies, you want to make a call on where you think the commodity is going forward. Made a big acquisition about a year ago, just before things started to turn down, which left them with a bit of a levered balance sheet. Given today’s prices and were he thinks they are going in the short term; he would hold off on buying this.
Real estate management based out of Toronto. They run closed-end funds for multi-institutional clients. Have started to do some direct real estate projects for shareholders. A good US presence and smart real estate investors. The stock is undervalued and this is a good buying opportunity. There is great upside in the US. Dividend yield of about 2.9%.
World’s largest commercial aerospace manufacturer. A good solid company over the long-term. but is cautious on it in the short term. We have just gone through a great commercial aerospace upside cycle in the last 7-8 years. Their 4th quarter was a concern. He thinks they are starting to lose sales. Would be interested at the $100 level, but at these levels he is cautious.
(A Top Pick Dec 10/14. Down 20.17%.) Just reported and had an excellent, excellent quarter. Had the best year in history. This would be his top pick in the biotech area. Trading at a crazy 6X PE despite having reported the best year in history. The global leader in HIV medication and hepatitis. Has just gone through the most successful drug launch in history. Trading at only 6X earnings.
(A Top Pick Dec 10/14. Down 26.57%.) Healthcare company. Has a lot of upside because they are developing a drug for treatment of hypertriglyceridemia. It should hopefully go into phase 3 trials by next year. Technically it is starting to outperform now. New CEO. A table pounder at this price.
For a 3-5 year hold? Good, solid healthcare conglomerate. There are very few companies with an AAA debt rating, and this is one of them. Because of that, they have low cost of capital which enables them to do a lot of things on the M&A front. A good solid hold for 3-5 years.
Their debt is pretty well termed out to 2020. Likes the stock and would be one of the “go to” names he would buy. Excellent assets in Canada, as well as in the Eagleford in the US. Outstanding management. It will be volatile in the short term because it has a fair bit of debt, which concerns people, but will be one of the survivors.
A rollup health care services company. Had a high profile last year and people made a lot of money on it, but in the last 6 months there has been a lot of negative news. Has concerns about the management set up. Not sure they have the structure in place for it to be a successful long-term business. He would want to see better execution for a number of quarters.
A good company in the casino business. Has a positive disposition towards the area in the long-term, but right now you do not want to touch the stock. Macau continues to be a big black hole.